Selected article for: "fallopian tube and scrna seq"

Author: Qi, Jing; Zhou, Yang; Hua, Jiao; Zhang, Liying; Bian, Jialin; Liu, Beibei; Zhao, Zicen; Jin, Shuilin
Title: The scRNA-seq Expression Profiling of the Receptor ACE2 and the Cellular Protease TMPRSS2 Reveals Human Organs Susceptible to SARS-CoV-2 Infection
  • Cord-id: 3ke000ov
  • Document date: 2021_1_2
  • ID: 3ke000ov
    Snippet: COVID-19 patients always develop multiple organ dysfunction syndromes other than lungs, suggesting the novel virus SARS-CoV-2 also invades other organs. Therefore, studying the viral susceptibility of other organs is important for a deeper understanding of viral pathogenesis. Angiotensin-converting enzyme II (ACE2) is the receptor protein of SARS-CoV-2, and TMPRSS2 promotes virus proliferation and transmission. We investigated the ACE2 and TMPRSS2 expression levels of cell types from 31 organs t
    Document: COVID-19 patients always develop multiple organ dysfunction syndromes other than lungs, suggesting the novel virus SARS-CoV-2 also invades other organs. Therefore, studying the viral susceptibility of other organs is important for a deeper understanding of viral pathogenesis. Angiotensin-converting enzyme II (ACE2) is the receptor protein of SARS-CoV-2, and TMPRSS2 promotes virus proliferation and transmission. We investigated the ACE2 and TMPRSS2 expression levels of cell types from 31 organs to evaluate the risk of viral infection using single-cell RNA sequencing (scRNA-seq) data. For the first time, we found that the gall bladder and fallopian tube are vulnerable to SARS-CoV-2 infection. Besides, the nose, heart, small intestine, large intestine, esophagus, brain, testis, and kidney are also identified to be high-risk organs with high expression levels of ACE2 and TMPRSS2. Moreover, the susceptible organs are grouped into three risk levels based on the ACE2 and TMPRSS2 expression. As a result, the respiratory system, digestive system, and urinary system are at the top-risk level for SARS-CoV-2 infection. This study provides evidence for SARS-CoV-2 infection in the human nervous system, digestive system, reproductive system, respiratory system, circulatory system, and urinary system using scRNA-seq data, which helps in the clinical diagnosis and treatment of patients.

    Search related documents:
    Co phrase search for related documents
    • acid detection and acute respiratory failure: 1
    • acid detection and liver function: 1
    • acid detection and low expression: 1
    • acid detection and low infection: 1, 2, 3, 4, 5
    • acid detection and low infection risk: 1
    • acid detection and low quality: 1, 2
    • acid testing and acute kidney injury: 1, 2
    • acid testing and acute respiratory failure: 1, 2
    • acid testing and liver function: 1, 2, 3
    • acid testing and low infection: 1, 2, 3, 4, 5
    • acid testing and low quality: 1
    • acute kidney injury and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute kidney injury and low expression: 1, 2, 3
    • acute kidney injury and low infection: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute kidney injury and low quality: 1, 2, 3, 4
    • acute myocardial injury and liver function: 1
    • acute respiratory failure and low infection: 1, 2, 3, 4, 5
    • acute respiratory failure and low infection risk: 1
    • acute respiratory failure and low quality: 1, 2, 3, 4, 5